About Tracy Ryan
Form D filings for NKore Biotherapeutics in 2023 list Tracy Ryan as executive officer and director.
Tracy Ryan first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Tracy Ryan in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Tracy Ryan works with at each company, as listed on that company's latest Form D.
NKore Biotherapeutics, LLC · Form D, Apr 13, 2023
RB
R Gregory Brophy
Chief Executive Officer and director
TB
Timothy Brahm
Director
DR
Diederik van der Reijt
Director